<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-561
Date of Submission: 2024-10-22

This report was submitted by a Pharmacist from Michael-Stewart Medical Center concerning patient ANON-PX-8391. The subject is a 74-year-old other with a significant medical history including chronic kidney disease, asthma, migraines, hypertension. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Atorvastatin administered via the Intramuscular route at a dosage of 231mg, initiated on 2024-09-24 for Hypercholesterolemia with the course ongoing.

On approximately 2024-10-12, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Nausea, Angioedema. The Nausea was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed beautiful and advised how. The current patient status regarding this symptom is 'Fatal'. The Angioedema was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Free under chance far remain year key. Dinner option tax campaign office establish huge with. Chair glass Congress speak particularly item that main. Character down specific.</data>
report_id: ADR-2024-561
report_date: '2024-10-22'
patient_details:
  patient_id: ANON-PX-8391
  gender: Other
  relevant_history:
  - chronic kidney disease
  - asthma
  - migraines
  - hypertension
  age_at_reaction: 74
suspected_drugs:
- drug_name: Atorvastatin
  dosage: 231mg
  route_of_administration: Intramuscular
  start_date: '2024-09-24'
  indication_for_use: Hypercholesterolemia
adverse_reactions:
- symptom_name: Nausea
  onset_date: '2024-10-12'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: true
  intervention_details: Prescribed beautiful and advised how.
- symptom_name: Angioedema
  onset_date: '2024-10-12'
  severity: Moderate
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive dechallenge
reporting_facility: Michael-Stewart Medical Center
reporter_type: Pharmacist
notes: Free under chance far remain year key. Dinner option tax campaign office establish
  huge with. Chair glass Congress speak particularly item that main. Character down
  specific.
